Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
04/2005
04/28/2005WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals
04/28/2005US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria
04/28/2005US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent
04/28/2005US20050090524 Novel adamantane derivatives
04/28/2005US20050090521 Tetrazoloquinoline, triazoloquinoline, and oxazoloquinoline compounds, e.g., 9-chloro-N-isopropoxytetrazolo[1,5-a]quinoline-4-carboxamide
04/28/2005US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative
04/28/2005US20050090497 Novel ester or amide derivatives
04/28/2005CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use
04/28/2005CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use
04/28/2005CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
04/28/2005CA2539761A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
04/28/2005CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use
04/27/2005EP1525180A2 Arylethanolamine beta2-adrenoreceptor agonist compounds
04/27/2005EP1034173B1 Method for producing 8-methoxy-quinoline carboxylic acids
04/27/2005EP1025097B1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d 4? receptor subtype ligands
04/27/2005EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same
04/27/2005CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy
04/26/2005US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent
04/26/2005US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders
04/26/2005US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases
04/26/2005US6884803 Phenylalkynes
04/26/2005US6884477 Electroluminescence device using liquid crystal compound
04/26/2005CA2213124C Benzoyl derivatives
04/26/2005CA2131182C Method for making intermediates useful in synthesis of retroviral protease inhibitors
04/26/2005CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation
04/21/2005WO2005035518A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
04/21/2005WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005WO2005035502A1 1-(quinoline amino) and 1-(isoquinoline amino)-substituted pentan-2-ols, method for their production and their use as anti-inflammatories
04/21/2005WO2005035471A1 Ether derivative
04/21/2005WO2005034955A1 Substituted quinolines as protein tyrosine kinase enzyme inhibitors
04/21/2005WO2005034939A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/21/2005WO2005034869A2 Compounds and compositions as protein kinase inhibitors
04/21/2005WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same
04/21/2005WO2005018529A3 Phenoxiacetic acid derivatives
04/21/2005WO2004106322A3 Polymorphs of aripiprazole
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085662 Process for the synthesis of nacyl-2-amino-4-alkoxy-5-nitrobenzoic acids
04/21/2005US20050085640 Novel crystalline forms of gatifloxacin
04/21/2005US20050085516 2-W-diaminocarboxylic acid compounds
04/21/2005US20050085471 Using 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-one; enzyme inhibitors; antithrombotic agents ; restenosis; atherosclerosis; antihistamines; chronic obsessive pulminary disease; autoimmune diseases; anticancer agents; antiinflammatory agents
04/21/2005US20050085467 Androgen receptor antagonists
04/21/2005US20050085466 such as 1-[4-(2-oxo-4-trifluoromethyl-1,2-dihydroquinolin-6-ylmethyl)benzenesulfonyl]-piperidine-3-carboxylic acid ethyl ester; for treatment of acne, alopecia, and oily skin; kits
04/21/2005US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties
04/21/2005US20050085413 Dimeric pharmaceutical compounds and their use
04/21/2005US20050084918 Method for the identification of agents that inhibit or promote cataracts and uses thereof
04/21/2005CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005CA2539878A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
04/21/2005CA2539587A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
04/21/2005CA2539572A1 1-(quinoline amino) and 1-(isoquinoline amino)-substituted pentan-2-ols, method for their production and their use as anti-inflammatories
04/20/2005CN1608072A Rare earth metal compounds and mixtures of these
04/20/2005CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties
04/20/2005CN1608053A Heterocyclic derivatives of glycinamide and its pharmaceutical uses
04/20/2005CN1608052A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
04/20/2005CN1607951A Quinoline derivatives as neuropeptide y antagonists
04/20/2005CN1197620C Use of immidazoquinolinamines as adjuvants in DNA vaccination
04/19/2005US6881753 Potassium channel inhibitors and method
04/19/2005US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/14/2005WO2005033119A1 Supramolecular compounds and their use as antitumour and antiviral agents
04/14/2005WO2005033100A1 Novel hypocholesterolemic compounds
04/14/2005WO2005033083A1 Process for producing high purity 3,5-dihydroxy-6-heptenoic acid derivative
04/14/2005WO2005033082A2 Cetp inhibitors and metabolites thereof
04/14/2005WO2005033081A1 4-piridinylmethylsulphonamide derivatives as fungicidal plant protection agents
04/14/2005WO2005033074A2 Salts and polymorphs of a potent antidiabetic compound
04/14/2005WO2005007111A3 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
04/14/2005US20050080267 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
04/14/2005US20050080264 Purity; in suspension with a aprotic solvent; heating 2-methylpiperazine with 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
04/14/2005US20050080243 Screening for enzyme inhibitors; signal transduction passageways' chelation enhancement fluorescence
04/14/2005US20050080242 Fluorescence assay for kinase activity
04/14/2005US20050080141 Amino diols useful in the treatment of alzheimer's disease
04/14/2005US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080105 3-thia-4-arylquinolin-2-one derivatives
04/14/2005US20050080104 Preparing 3-[(4S)-5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl]benzonitrile by reacting an ester of 4,4,4-trifluoro-3-oxobutanoate with 1,3-cyclohexanedione and 3-cyanobenzaldehyde, , dehydrating and de-esterifying the intermeidate
04/14/2005US20050080082 Potassium channel modulators
04/14/2005US20050080079 N-[4-[[4-(5-chloro-2-hydroxyphenyl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-3-quinolinyl]thio]phenyl]ethanesulfonamide for example; potassium channel modulators for treating erectile dysfunction and irritable bowel syndrome
04/14/2005US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators
04/14/2005CA2545479A1 Compounds comprising a nitric oxide moiety for inducing expression of apoa1 for the treatment of cardiovascular disorders
04/14/2005CA2541822A1 Novel hypocholesterolemic compounds
04/14/2005CA2540536A1 Salts and polymorphs of a potent antidiabetic compound
04/14/2005CA2540231A1 Cetp inhibitors and metabolites thereof
04/14/2005CA2537486A1 4-piridinylmethylsulphonamide derivatives as fungicidal plant protection agents
04/13/2005EP1522541A1 Novel hypocholesterolemic compounds
04/13/2005EP1031555B1 Difluoromethoxybenzene derivatives and their use as intermediates
04/13/2005CN1606556A Triazolo-quinolin derivatives useful as adenosine receptor ligands
04/13/2005CN1606555A Imidazoquinoline derivatives
04/13/2005CN1196692C Substituted benzopyran derivatives for the treatment of inflammation
04/13/2005CN1196683C Amino-compound
04/12/2005US6878743 Controlling apoptosis; central nervous system disorders
04/12/2005US6878736 Histamine H3 receptor ligands
04/12/2005US6878721 Beta2-adrenoceptor agonists
04/12/2005US6878720 VEGF receptor tyrosine kinase inhibitors
04/12/2005US6878713 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
04/12/2005US6878704 Heterocyclic mutilin esters and their use as antibacterials
04/12/2005US6878183 Sublimation purifying method and apparatus
04/12/2005CA2203936C Boronic ester and acid compounds, synthesis and uses
04/07/2005WO2005030792A2 Quinoline potassium channel inhibitors
04/07/2005WO2005030774A1 Hcv inhibitors and methods of using them
04/07/2005WO2005030752A1 8-cyanoquinolonecarboxylic acid derivative
04/07/2005WO2005030732A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030725A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation